Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1327-1332
Published online before print August 19, 2002, doi: 10.1161/01.CIR.0000028421.91733.20
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/11/1327    most recent
01.CIR.0000028421.91733.20v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, D. J.A.
Right arrow Articles by Spiller, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, D. J.A.
Right arrow Articles by Spiller, G. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Nutrition
Right arrow Pulmonary biology and circulation
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress

(Circulation. 2002;106:1327.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Dose Response of Almonds on Coronary Heart Disease Risk Factors: Blood Lipids, Oxidized Low-Density Lipoproteins, Lipoprotein(a), Homocysteine, and Pulmonary Nitric Oxide

A Randomized, Controlled, Crossover Trial

David J.A. Jenkins, MD; Cyril W.C. Kendall, PhD; Augustine Marchie, BSc; Tina L. Parker, RD; Philip W. Connelly, PhD; Wei Qian, PhD; James S. Haight, MD; Dorothea Faulkner, RD; Edward Vidgen, BSc; Karen G. Lapsley, DSc; Gene A. Spiller, PhD

From Clinical Nutrition and Risk Factor Modification Center (D.J.A.J., C.W.C.K., A.M., E.V.), Department of Medicine, Division of Endocrinology and Metabolism (P.W.C.), and Department of Surgery, Division of Otolaryngology (W.Q., J.S.H.), St Michael’s Hospital, Toronto, Ontario, Canada; Departments of Nutritional Sciences (D.J.A.J., C.W.C.K., A.M., T.L.P., D.F., E.V.), Biochemistry (P.W.C.), and Laboratory Medicine and Pathobiology (P.W.C.), Faculty of Medicine, University of Toronto, Toronto, Ontario; the Almond Board of California (K.G.L.), Modesto, Calif; and Health Research and Studies Center (G.A.S.), Los Altos, Calif.

Correspondence to David J.A. Jenkins, Clinical Nutrition and Risk Factor Modification Center, St Michael’s Hospital, 61 Queen St E, Toronto, Ontario, Canada, M5C 2T2. E-mail cyril.kendall{at}utoronto.ca

Background— Although recent studies have indicated that nut consumption may improve levels of blood lipids, nuts are not generally recommended as snacks for hyperlipidemic subjects because of their high fat content. Furthermore, the effective dose is still unknown.

Methods and Results— The dose-response effects of whole almonds, taken as snacks, were compared with low-saturated fat (<5% energy) whole-wheat muffins (control) in the therapeutic diets of hyperlipidemic subjects. In a randomized crossover study, 27 hyperlipidemic men and women consumed 3 isoenergetic (mean 423 kcal/d) supplements each for 1 month. Supplements provided 22.2% of energy and consisted of full-dose almonds (73±3 g/d), half-dose almonds plus half-dose muffins, and full-dose muffins. Fasting blood, expired air, blood pressure, and body weight measurements were obtained at weeks 0, 2, and 4. Mean body weights differed <300 g between treatments. The full-dose almonds produced the greatest reduction in levels of blood lipids. Significant reductions from baseline were seen on both half- and full-dose almonds for LDL cholesterol (4.4±1.7%, P=0.018, and 9.4±1.9%, P<0.001, respectively) and LDL:HDL cholesterol (7.8±2.2%, P=0.001, and 12.0±2.1%, P<0.001, respectively) and on full-dose almonds alone for lipoprotein(a) (7.8±3.5%, P=0.034) and oxidized LDL concentrations (14.0±3.8%, P<0.001), with no significant reductions on the control diet. No difference was seen in pulmonary nitric oxide between treatments.

Conclusions— Almonds used as snacks in the diets of hyperlipidemic subjects significantly reduce coronary heart disease risk factors, probably in part because of the nonfat (protein and fiber) and monounsaturated fatty acid components of the nut.


Key Words: hypercholesterolemia • lipids • lipoproteins • diet • antioxidants




This article has been cited by other articles:


Home page
Arch Intern MedHome page
D. J. A. Jenkins, J. M. W. Wong, C. W. C. Kendall, A. Esfahani, V. W. Y. Ng, T. C. K. Leong, D. A. Faulkner, E. Vidgen, K. A. Greaves, G. Paul, et al.
The Effect of a Plant-Based Low-Carbohydrate ("Eco-Atkins") Diet on Body Weight and Blood Lipid Concentrations in Hyperlipidemic Subjects
Arch Intern Med, June 8, 2009; 169(11): 1046 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Ros
Nuts and novel biomarkers of cardiovascular disease
Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1649S - 1656S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. A Cassady, J. H Hollis, A. D Fulford, R. V Considine, and R. D Mattes
Mastication of almonds: effects of lipid bioaccessibility, appetite, and hormone response
Am. J. Clinical Nutrition, March 1, 2009; 89(3): 794 - 800.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. J. A. Jenkins, C. W. C. Kendall, A. Marchie, A. R. Josse, T. H. Nguyen, D. A. Faulkner, K. G. Lapsley, and J. Blumberg
Almonds Reduce Biomarkers of Lipid Peroxidation in Older Hyperlipidemic Subjects
J. Nutr., May 1, 2008; 138(5): 908 - 913.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Shah, B. Adams-Huet, and A. Garg
Effect of high-carbohydrate or high-cis-monounsaturated fat diets on blood pressure: a meta-analysis of intervention trials
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1251 - 1256.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. J. Sheridan, J. N. Cooper, M. Erario, and C. E. Cheifetz
Pistachio Nut Consumption and Serum Lipid Levels
J. Am. Coll. Nutr., April 1, 2007; 26(2): 141 - 148.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. H. Opie
Metabolic Syndrome
Circulation, January 23, 2007; 115(3): e32 - e35.
[Full Text] [PDF]


Home page
J. Nutr.Home page
D. J. A. Jenkins, C. W. C. Kendall, A. R. Josse, S. Salvatore, F. Brighenti, L. S. A. Augustin, P. R. Ellis, E. Vidgen, and A. V. Rao
Almonds Decrease Postprandial Glycemia, Insulinemia, and Oxidative Damage in Healthy Individuals
J. Nutr., December 1, 2006; 136(12): 2987 - 2992.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
L. K Nies, A. A Cymbala, S. L Kasten, D. G Lamprecht, and K. L Olson
Complementary and Alternative Therapies for the Management of Dyslipidemia
Ann. Pharmacother., November 1, 2006; 40(11): 1984 - 1992.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al.
Managing Abnormal Blood Lipids: A Collaborative Approach
Circulation, November 15, 2005; 112(20): 3184 - 3209.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Shah, B. Adams-Huet, J. P. Bantle, R. R. Henry, K. A. Griver, S. K. Raatz, L. J. Brinkley, G. M. Reaven, and A. Garg
Effect of a High-Carbohydrate Versus a High--cis-Monounsaturated Fat Diet on Blood Pressure in Patients With Type 2 Diabetes
Diabetes Care, November 1, 2005; 28(11): 2607 - 2612.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Mukuddem-Petersen, W. Oosthuizen, and J. C. Jerling
A Systematic Review of the Effects of Nuts on Blood Lipid Profiles in Humans
J. Nutr., September 1, 2005; 135(9): 2082 - 2089.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C.-Y. Chen, P. E. Milbury, K. Lapsley, and J. B. Blumberg
Flavonoids from Almond Skins Are Bioavailable and Act Synergistically with Vitamins C and E to Enhance Hamster and Human LDL Resistance to Oxidation
J. Nutr., June 1, 2005; 135(6): 1366 - 1373.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M.-P. St-Onge
Dietary fats, teas, dairy, and nuts: potential functional foods for weight control?
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 7 - 15.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
O. H Franco, L. Bonneux, C. de Laet, A. Peeters, E. W Steyerberg, and J. P Mackenbach
The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%
BMJ, December 18, 2004; 329(7480): 1447 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. R Ellis, C. W. Kendall, Y. Ren, C. Parker, J. F Pacy, K. W Waldron, and D. J. Jenkins
Role of cell walls in the bioaccessibility of lipids in almond seeds
Am. J. Clinical Nutrition, September 1, 2004; 80(3): 604 - 613.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Ros, I. Nunez, A. Perez-Heras, M. Serra, R. Gilabert, E. Casals, and R. Deulofeu
A Walnut Diet Improves Endothelial Function in Hypercholesterolemic Subjects: A Randomized Crossover Trial
Circulation, April 6, 2004; 109(13): 1609 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. M. Marcovina, M. L. Koschinsky, J. J. Albers, and S. Skarlatos
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions
Clin. Chem., November 1, 2003; 49(11): 1785 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. J. Jenkins, C. W. Kendall, A. Marchie, A. L Jenkins, L. S. Augustin, D. S Ludwig, N. D Barnard, and J. W Anderson
Type 2 diabetes and the vegetarian diet
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 610S - 616.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. J. A. Jenkins, C. W. C. Kendall, A. Marchie, D. A. Faulkner, J. M. W. Wong, R. de Souza, A. Emam, T. L. Parker, E. Vidgen, K. G. Lapsley, et al.
Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein
JAMA, July 23, 2003; 290(4): 502 - 510.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Sabate, E. Haddad, J. S Tanzman, P. Jambazian, and S. Rajaram
Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial
Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1379 - 1384.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
A Bit of Joy to Share About Almonds
Journal Watch Cardiology, October 4, 2002; 2002(1004): 3 - 3.
[Full Text]